The Immunogenetics of Granulomatous Diseases.
Dermatology
Diseases
Granulomatous
Non-infectious
Skin
Journal
Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103
Informations de publication
Date de publication:
2022
2022
Historique:
entrez:
14
3
2022
pubmed:
15
3
2022
medline:
17
3
2022
Statut:
ppublish
Résumé
Non-infectious granulomatous skin diseases are a wide category of well-defined reactive inflammatory conditions that share main similarities. While cutaneous sarcoidosis is the prototype of non-infectious (sterile) granulomatous dermatitides, there are several other entities in this group including granuloma annulare and necrobiosis lipoidica. Non-infectious granulomatous diseases are caused by complex associations between genetic situations and environmental triggers resulting in a variety of cutaneous and systemic manifestations. The genetic backgrounds of these diseases are the main topic of this manuscript.
Identifiants
pubmed: 35286702
doi: 10.1007/978-3-030-92616-8_13
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
349-368Informations de copyright
© 2022. Springer Nature Switzerland AG.
Références
Abdallah A, Sato H, Grutters J, Veeraraghavan S, Lympany P, Ruven H, van den Bosch J, Wells A, Du Bois R, Welsh K (2003) Inhibitor kappa B-alpha (IκB-α) promoter polymorphisms in UK and Dutch sarcoidosis. Genes Immun 4:450–454
pubmed: 12944982
Adrianto I, Lin CP, Hale JJ, Levin AM, Datta I, Parker R, Adler A, Kelly JA, Kaufman KM, Lessard CJ (2012) Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility. PloS One 7
Akahoshi M, Ishihara M, Remus N, Uno K, Miyake K, Hirota T, Nakashima K, Matsuda A, Kanda M, Enomoto T (2004) Association between IFNA genotype and the risk of sarcoidosis. Hum Genet 114:503–509
pubmed: 15004750
Alegre V, Winkelmann R (1988) A new histopathologic feature of necrobiosis lipoidica diabeticorum: lymphoid nodules. J Cutan Pathol 15:75–77
pubmed: 3372792
Ali M, Atwan A, Gonzalez M (2010) Cutaneous sarcoidosis: updates in the pathogenesis. J Eur Acad Dermatol Venereol 24:747–755
pubmed: 20015176
Arnett HA, Escobar SS, Gonzalez-Suarez E, Budelsky AL, Steffen LA, Boiani N, Zhang M, Siu G, Brewer AW, Viney JL (2007) BTNL2, a butyrophilin/B7-like molecule, is a negative costimulatory molecule modulated in intestinal inflammation. J Immunol 178:1523–1533
pubmed: 17237401
Bach TL, Chen Q-M, Kerr WT, Wang Y, Lian L, Choi JK, Wu D, Kazanietz MG, Koretzky GA, Zigmond S (2007) Phospholipase Cβ is critical for T cell chemotaxis. J Immunol 179:2223–2227
pubmed: 17675482
Barron D, Cootauco M, Cohen BA (1997) Granuloma annulare. A clinical review. Lippincotts Prim Care Pract 1:33–39
pubmed: 9166607
Baykal C, Özkaya-Bayazit E, Kaymaz R (2002) Granuloma annulare possibly triggered by antitetanus vaccination. J Eur Acad Dermatol Venereol 16:516–518
pubmed: 12428851
Bergman R, Pam Z, Lichtig C, Reiter I, Friedman-Birnbaum R (1993) Localized granuloma annulare. Histopathological and direct immunofluorescence study of early lesions, and the adjacent normal-looking skin of actively spreading lesions. Am J Dermatopathol 15:544–548
pubmed: 8311184
Berlin M, Fogdell-Hahn A, Olerup O, Eklund A, Grunewald J (1997) HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 156:1601–1605
pubmed: 9372682
Boateng B, Hiller D, Albrecht H, Hornstein O (1993) Cutaneous microcirculation in pretibial necrobiosis lipoidica. Comparative laser Doppler flowmetry and oxygen partial pressure determinations in patients and healthy probands. Der Hautarzt; Zeitschrift fur Dermatologie. Venerologie, Und Verwandte Gebiete 44:581–586
Bogunia-Kubik K, Koscinska K, Suchnicki K, Lange A (2006) HSP70-hom gene single nucleotide (+ 2763 G/A and+ 2437 C/T) polymorphisms in sarcoidosis. Int J Immunogenet 33:135–140
pubmed: 16611259
Bogunia-Kubik K, Tomeczko J, Suchnicki K, Lange A (2001) HLA-DRB1* 03, DRB1* 11 or DRB1* 12 and their respective DRB3 specificities in clinical variants of sarcoidosis. Tissue Antigens 57:87–90
pubmed: 11169267
Bombieri C, Luisetti M, Belpinati F, Zuliani E, Beretta A, Baccheschi J, Casali L, Pignatti PF (2000) Increased frequency of CFTR gene mutations in sarcoidosis: a case/control association study. Eur J Hum Genet 8:717–720
pubmed: 10980579
Boring L, Gosling J, Chensue SW, Kunkel SL, Farese RV, Broxmeyer HE, Charo IF (1997) Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in CC chemokine receptor 2 knockout mice. J Clin Investig 100:2552–2561
pubmed: 9366570
pmcid: 508456
Buechner S, Winkelmann R, Banks PM (1983) Identification of T-cell subpopulations in granuloma annulare. Arch Dermatol 119:125–128
pubmed: 6218788
Chen ES, Moller DR (2014) Etiologic role of infectious agents. In: (eds) Seminars in respiratory and critical care medicine. Thieme Medical Publishers, pp 285–295
Chu P, Connolly MK, LeBoit PE (1994) The histopathologic spectrum of palisaded neutrophilic and granulomatous dermatitis in patients with collagen vascular disease. Arch Dermatol 130:1278–1283
pubmed: 7944509
Conron M, Bondeson J, Pantelidis P, Beynon HL, Feldmann M, duBois RM, Foxwell BM (2001) Alveolar macrophages and T cells from sarcoid, but not normal lung, are permissive to adenovirus infection and allow analysis of NF-κ B–dependent signaling pathways. Am J Respir Cell Mol Biol 25:141–149
pubmed: 11509322
Dahl MV, Ullman S, Goltz RW (1977) Vasculitis in granuloma annulare: histopathology and direct immunofluorescence. Arch Dermatol 113:463–467
pubmed: 322621
Dai C, Shih S, Ansari A, Kwak Y, Sami N (2019) Biologic therapy in the treatment of cutaneous sarcoidosis: a literature review. Am J Clin Dermatol 20:409–422
pubmed: 30895525
Daniil Z, Mollaki V, Malli F, Koutsokera A, Antoniou K, Rodopoulou P, Gourgoulianis K, Zintzaras E, Vassilopoulos G (2013) Polymorphisms and haplotypes in MyD88 are associated with the development of sarcoidosis: a candidate-gene association study. Mol Biol Rep 40:4281–4286
pubmed: 23666053
Davids JR, Kolman BH, Billman GF, Krous HF (1993) Subcutaneous granuloma annulare: recognition and treatment. J Pediatr Orthop 13:582–586
pubmed: 8376556
Davoudi S, Chang VS, Navarro-Gomez D, Stanwyck LK, Sevgi DD, Papavasileiou E, Ren A, Uchiyama E, Sullivan L, Lobo A-M (2018) Association of genetic variants in RAB23 and ANXA11 with uveitis in sarcoidosis. Mol Vis 24:59
pubmed: 29416296
pmcid: 5783744
de Smet MD, Ramadan A (2001) Circulating antibodies to inducible heat shock protein 70 in patients with uveitis. Ocul Immunol Inflamm 9:85–92
pubmed: 11449324
Doty JD, Mazur JE, Judson MA (2005) Treatment of sarcoidosis with infliximab. Chest 127:1064–1071
pubmed: 15764796
Dubey S, Merry P (2007) Interstitial granulomatous dermatitis (Ackerman’s syndrome) in SLE presenting with the ‘rope sign.’ Rheumatology 46:80
pubmed: 16935918
Duvefelt K, Anderson M, Fogdell-Hahn A, Hillert J (2004) A NOTCH4 association with multiple sclerosis is secondary to HLA-DR* 1501. Tissue Antigens 63:13–20
pubmed: 14651518
Eishi Y (2013) Etiologic link between sarcoidosis and Propionibacterium acnes. Respir Investig 51:56–68
pubmed: 23790733
Erfurt-Berge C, Seitz A-T, Rehse C, Wollina U, Schwede K, Renner R (2012) Update on clinical and laboratory features in necrobiosis lipoidica: a retrospective multicentre study of 52 patients. Eur J Dermatol 22:770–775
pubmed: 23114030
Evans C, Pereira R, Yuen C, Holden C (1988) Anti-collagen antibodies in granuloma annulare and necrobiosis lipoidica. Clin Exp Dermatol 13:252–254
pubmed: 3246092
Fayyazi A, Schweyer S, Eichmeyer B, Herms J, Hemmerlein B, Radzun H, Berger H (2000) Expression of IFNγ, coexpression of TNFα and matrix metalloproteinases and apoptosis of T lymphocytes and macrophages in granuloma annulare. Arch Dermatol Res 292:384–390
pubmed: 10994772
Fischer A, Ellinghaus D, Nutsua M, Hofmann S, Montgomery CG, Iannuzzi MC, Rybicki BA, Petrek M, Mrazek F, Pabst S (2015) Identification of immune-relevant factors conferring sarcoidosis genetic risk. Am J Respir Crit Care Med 192:727–736
pubmed: 26051272
pmcid: 4595678
Fischer A, Nothnagel M, Franke A, Jacobs G, Saadati HR, Gaede KI, Rosenstiel P, Schürmann M, Müller-Quernheim J, Schreiber S (2011) Association of inflammatory bowel disease risk loci with sarcoidosis, and its acute and chronic subphenotypes. Eur Respir J 37:610–616
pubmed: 20650992
Fischer A, Schmid B, Ellinghaus D, Nothnagel M, Gaede KI, Schürmann M, Lipinski S, Rosenstiel P, Zissel G, Höhne K (2012) A novel sarcoidosis risk locus for Europeans on chromosome 11q13. 1. Am J Respir Crit Care Med 186:877–885
pubmed: 22837380
Fischer A, Valentonyte R, Nebel A, Nothnagel M, Müller-Quernheim J, Schürmann M, Schreiber S (2008) Female-specific association of CC chemokine receptor 5 gene polymorphisms with Löfgren’s syndrome. J Mol Med 86:553–561
pubmed: 18311470
Fontenot A, King T (2018) Pathology and pathogenesis of sarcoidosis. U: UpToDate, Post TW ur. UpToDate [Internet]. UpToDate, Waltham, MA
Forman JD, Klein JT, Silver RF, Liu MC, Greenlee BM, Moller DR (1994) Selective activation and accumulation of oligoclonal V beta-specific T cells in active pulmonary sarcoidosis. J Clin Investig 94:1533–1542
pubmed: 7929830
pmcid: 295302
Franke A, Fischer A, Nothnagel M, Becker C, Grabe N, Till A, Lu T, Müller-Quernheim J, Wittig M, Hermann A (2008) Genome-wide association analysis in sarcoidosis and Crohn’s disease unravels a common susceptibility locus on 10p12. 2. Gastroenterology 135:1207–1215
pubmed: 18723019
Fridlender ZG, Schwartz A, Kohan M, Amir G, Glazer M, Berkman N (2010) Association between CD14 gene polymorphisms and disease phenotype in sarcoidosis. Respir Med 104:1336–1343
pubmed: 20430603
Friedman-Birnbaum R, Ludatscher RM (1986) Comparative ultrastructural study of generalized and localized granuloma annulare. Am J Dermatopathol 8:302–308
pubmed: 3766919
Friedman-Birnbaum R, Haim S, Gideone O, Barzilai A (1978) Histocompatibility antigens in granuloma annulare: comparative study of the generalized and localized types. Br J Dermatol 98:425–428
pubmed: 638048
Friedman SJ, Winkelmann R (1987) Familial granuloma annulare. Report of two cases and review of the literature. J Am Acad Dermatol 16:600–605
pubmed: 3819101
Gange R, Black MM, Carrington P (1979) Defective neutrophil migration in granuloma annulare, necrobiosis lipoidica, and sarcoidosis. Arch Dermatol 115:32–35
pubmed: 367286
Gardner J, Kennedy HG, Hamblin A, Jones E (1984) HLA associations in sarcoidosis: a study of two ethnic groups. Thorax 39:19–22
pubmed: 6582657
pmcid: 459715
Gerke V, Moss SE (2002) Annexins: from structure to function. Physiol Rev 82:331–371
pubmed: 11917092
Gilbert S, Steinbrech DS, Landas SK, Hunninghake GW (1993) Amounts of angiotensin-converting enzyme mRNA reflect the burden of granulomas in granulomatous lung disease. Am Rev Respir Dis 148:483–486
pubmed: 8393640
Gorlova O, Martin J-E, Rueda B, Koeleman BP, Ying J, Teruel M, Diaz-Gallo L-M, Broen JC, Vonk MC, Simeon CP (2011) Identification of novel genetic markers associated with clinical phenotypes of systemic sclerosis through a genome-wide association strategy. PLoS Genet 7
Grunewald J, Brynedal B, Darlington P, Nisell M, Cederlund K, Hillert J, Eklund A (2010) Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients. Respir Res 11:25
pubmed: 20187937
pmcid: 2846896
Grunewald J, Eklund A, Olerup O (2004) Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients. Am J Respir Crit Care Med 169:696–702
pubmed: 14656748
Grutters J (2005) Genetics of sarcoidosis: Role of co-stimulatory genes? Respiration 72:227–228
pubmed: 15942288
Grutters J, Sato H, Pantelidis P, Ruven H, McGrath D, Wells A, Van den Bosch J, Welsh K, Du Bois R (2003a) Analysis of IL6 and IL1A gene polymorphisms in UK and Dutch patients with sarcoidosis. Sarcoidosis Vasculitis Diff Lung Dis Offic J Wasog 20:20–27
Grutters JC, Sato H, Pantelidis P, Lagan AL, McGrath DS, Lammers J-WJ, van den Bosch JM, Wells AU, du Bois RM, Welsh KI (2002) Increased frequency of the uncommon tumor necrosis factor− 857T allele in British and Dutch patients with sarcoidosis. Am J Respir Crit Care Med 165:1119–1124
pubmed: 11956055
Grutters JC, Sato H, Welsh KI, du Bois RM (2003b) The importance of sarcoidosis genotype to lung phenotype. Am J Respir Cell Mol Biol 29:S59
pubmed: 14503556
Haimovic A, Sanchez M, Judson MA, Prystowsky S (2012) Sarcoidosis: a comprehensive review and update for the dermatologist: part I. Cutaneous disease. J Am Acad Dermatol 66:699. e691–699. e618
Handa T, Nagai S, Ito I, Tabuena R, Shigematsu M, Hamada K, Kitaichi M, Izumi T, Aoyama T, Toguchida J (2005) Polymorphisms of B7 (CD80 and CD86) genes do not affect disease susceptibility to sarcoidosis. Respiration 72:243–248
pubmed: 15942292
Hattori T, Konno S, Takahashi A, Isada A, Shimizu K, Shimizu K, Taniguchi N, Gao P, Yamaguchi E, Hizawa N (2010) Genetic variants in mannose receptor gene (MRC1) confer susceptibility to increased risk of sarcoidosis. BMC Med Genet 11:151
pubmed: 21029423
pmcid: 2987761
Hawryluk EB, Izikson L, English JC (2010) Non-infectious granulomatous diseases of the skin and their associated systemic diseases. Am J Clin Dermatol 11:171–181
pubmed: 20184390
Heath CR, David J, Taylor SC (2012) Sarcoidosis: are there differences in your skin of color patients? J Am Acad Dermatol 66:121. e121–121. e114
Hedfors E, Lindström F (1983) HLA‐B8/DR3 in sarcoidosis: correlation to acute onset disease with arthritis. Tissue Antigens 22:200–203
Heron M, Grutters J, Van Moorsel C, Ruven H, Huizinga T, Van Der Helm-van MA, Claessen A, Van Den Bosch J (2009a) Variation in IL7R predisposes to sarcoid inflammation. Genes Immun 10:647–653
pubmed: 19626041
Heron M, Grutters JC, Van Moorsel CH, Ruven HJ, Kazemier KM, Claessen AM, Van den Bosch JM (2009b) Effect of variation in ITGAE on risk of sarcoidosis, CD103 expression, and chest radiography. Clin Immunol 133:117–125
pubmed: 19604725
Heron M, Van Moorsel C, Grutters J, Huizinga T, van der Helm-van MA, Nagtegaal M, Ruven H, van den Bosch J (2011) Genetic variation in GREM1 is a risk factor for fibrosis in pulmonary sarcoidosis. Tissue Antigens 77:112–117
pubmed: 21214523
Hill MR, Papafili A, Booth H, Lawson P, Hubner M, Beynon H, Read C, Lindahl G, Marshall RP, McAnulty RJ (2006) Functional prostaglandin-endoperoxide synthase 2 polymorphism predicts poor outcome in sarcoidosis. Am J Respir Crit Care Med 174:915–922
pubmed: 16840740
Hizawa N, Yamaguchi E, Furuya K, Jinushi E, ITO A, Kawakami Y (1999) The role of the CC chemokine receptor 2 gene polymorphism V64I (CCR2-64I) in sarcoidosis in a Japanese population. Am J Respir Crit Care Med 159:2021–2023
Ho KKL, O’loughlin S, Powell F (1992) Familial non‐diabetic necrobiosis lipoidica. Australas J Dermatol 33:31–34
Hofmann S, Fischer A, Nothnagel M, Jacobs G, Schmid B, Wittig M, Franke A, Gaede KI, Schürmann M, Petrek M (2013) Genome-wide association analysis reveals 12q13. 3–q14. 1 as new risk locus for sarcoidosis. Eur Respir J 41:888–900
pubmed: 22936702
Hofmann S, Fischer A, Till A, Müller-Quernheim J, Häsler R, Franke A, Gäde K, Schaarschmidt H, Rosenstiel P, Nebel A (2011) A genome-wide association study reveals evidence of association with sarcoidosis at 6p12. 1. Eur Respir J 38:1127–1135
pubmed: 21540310
Hofmann S, Franke A, Fischer A, Jacobs G, Nothnagel M, Gaede KI, Schürmann M, Müller-Quernheim J, Krawczak M, Rosenstiel P (2008) Genome-wide association study identifies ANXA11 as a new susceptibility locus for sarcoidosis. Nat Genet 40:1103
pubmed: 19165924
Hughes D, Dörk T, Stuhrmann M, Graham C (2001) Mutation and haplotype analysis of the CFTR gene in atypically mild cystic fibrosis patients from Northern Ireland. J Med Genet 38:136–139
Hunninghake G (1984) Release of interleukin-1 by alveolar macrophages of patients with active pulmonary sarcoidosis. Am Rev Respir Dis 129:569–572
pubmed: 6608889
Hutyrova B, Pantelidis P, Drabek J, Zurkova M, Kolek V, Lenhart K, Welsh KI, du Bois RM, Petrek M (2002) Interleukin-1 gene cluster polymorphisms in sarcoidosis and idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 165:148–151
pubmed: 11790645
Iannuzzi MC, Maliarik MJ, Poisson LM, Rybicki BA (2003) Sarcoidosis susceptibility and resistance HLA-DQB1 alleles in African Americans. Am J Respir Crit Care Med 167:1225–1231
pubmed: 12615619
Iannuzzi MC, Rybicki BA (2007) Genetics of sarcoidosis: candidate genes and genome scans. Proc Am Thorac Soc 4:108–116
pubmed: 17202299
pmcid: 2647608
Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Medical progress. Sarcoidosis. N Eng J Med 357:2153–2165
Ishihara M, Ohno S, Ishida T, Ando H, Naruse T, Nose Y, Inoko H (1994) Molecular genetic studies of HLA class II alleles in sarcoidosis. Tissue Antigens 43:238–241
pubmed: 8085259
Ishihara M, Ohno S, Ishida T, Mizuki N, Ando H, Naruse T, Ishihara H, Inoko H (1995) Genetic polymorphisms of the TNFB and HSP70 genes located in the human major histocompatibility complex in sarcoidosis. Tissue Antigens 46:59–62
pubmed: 7482498
Janssen R, Grutters J, Ruven H, Zanen P, Sato H, Welsh K, Du Bois R, Van Den Bosch J (2004) No association between interleukin-18 gene polymorphisms and haplotypes in Dutch sarcoidosis patients. Tissue Antigens 63:578–583
pubmed: 15140035
Jonth AC, Silveira L, Fingerlin TE, Sato H, Luby JC, Welsh KI, Rose CS, Newman LS, Du Bois RM, Maier LA (2007) TGF-β1 variants in chronic beryllium disease and sarcoidosis. J Immunol 179:4255–4262
pubmed: 17785866
Judson MA, Baughman RP, Costabel U, Drent M, Gibson KF, Raghu G, Shigemitsu H, Barney JB, Culver DA, Hamzeh NY (2014) Safety and efficacy of ustekinumab or golimumab in patients with chronic sarcoidosis. Eur Respir J 44:1296–1307
pubmed: 25034562
Kallioinen M, Sandberg M, Kinnunen T, Oikarinen A (1992) Collagen synthesis in granuloma annulare. J Invest Dermatol 98
Kamil ZS, Chen T, Ghazarian D (2015) Non-infectious granulomatous conditions of the skin: a clinicopathological approach to diagnosis. J Clin Pathol 68:982–991
pubmed: 25900338
Kim HS, Choi D, Lim LL, Allada G, Smith JR, Austin CR, Doyle TM, Goodwin KA, Rosenbaum JT, Martin TM (2011) Association of interleukin 23 receptor gene with sarcoidosis. Dis Markers 31:17–24
pubmed: 21846945
pmcid: 3826587
Kishore A, Petrek M (2013) Immunogenetics of sarcoidosis. J Int Trends Immun 1:43–53
Knoell KA (2009) Efficacy of adalimumab in the treatment of generalized granuloma annulare in monozygotic twins carrying the 8.1 ancestral haplotype. Arch Dermatol 145:610–611
pubmed: 19451522
Knoops B, Goemaere J, Van der Eecken V, Declercq J-P (2011) Peroxiredoxin 5: structure, mechanism, and function of the mammalian atypical 2-Cys peroxiredoxin. Antioxid Redox Signal 15:817–829
pubmed: 20977338
Koh M, Majewski B, Barter S, Rhodes E (1984) Increased plasma fibronectin in diabetes mellitus, necrobiosis lipoidica and widespread granuloma annulare. Clin Exp Dermatol 9:293–297
pubmed: 6733961
Koth LL, Solberg OD, Peng JC, Bhakta NR, Nguyen CP, Woodruff PG (2011) Sarcoidosis blood transcriptome reflects lung inflammation and overlaps with tuberculosis. Am J Respir Crit Care Med 184:1153–1163
pubmed: 21852540
pmcid: 3262024
Kruit A, Grutters JC, Ruven HJ, van Moorsel CH, Weiskirchen R, Mengsteab S, van den Bosch JM (2006) Transforming growth factor-β gene polymorphisms in sarcoidosis patients with and without fibrosis. Chest 129:1584–1591
pubmed: 16778279
Labunski S, Posern G, Ludwig S, Kundt G, Brocker E-B, Kunz M (2001) Tumour necrosis factor-a promoter polymorphism in erythema nodosum. Acta Derm Venereol 81:18–21
pubmed: 11411907
Lembrechts R, Pintelon I, Schnorbusch K, Timmermans J-P, Adriaensen D, Brouns I (2011) Expression of mechanogated two-pore domain potassium channels in mouse lungs: special reference to mechanosensory airway receptors. Histochem Cell Biol 136:371
pubmed: 21822716
Levin A, Iannuzzi M, Montgomery C, Trudeau S, Datta I, McKeigue P, Fischer A, Nebel A, Rybicki B (2013) Association of ANXA11 genetic variation with sarcoidosis in African Americans and European Americans. Genes Immun 14:13–18
pubmed: 23151485
Li H, Zhao X, Wang J, Zong M, Yang H (2017) Bioinformatics analysis of gene expression profile data to screen key genes involved in pulmonary sarcoidosis. Gene 596:98–104
pubmed: 27682024
Lopez-Campos JL, Rodriguez-Rodriguez D, Rodriguez-Becerra E, Michavila IA, Guerra JF, Hernandez FJG, Casanova A, de Córdoba Gamero JF, Romero-Ortiz A, Arellano-Orden E (2009) Cyclooxygenase-2 polymorphisms confer susceptibility to sarcoidosis but are not related to prognosis. Respir Med 103:427–433
pubmed: 19042116
Luisetti M, Beretta A, Casali L (2000) Genetic aspects in sarcoidosis. Eur Respir J 16:768–780
pubmed: 11106224
Maillard I, Adler SH, Pear WS (2003) Notch and the immune system. Immunity 19:781–791
pubmed: 14670296
Majewski B, Barter S, Rhodes E (1981) Serum α2 globulin levels in granuloma annulare and necrobiosis lipoidica. Br J Dermatol 105:557–562
pubmed: 6170304
Maliarik MJ, Rybicki BA, Malvitz E, Sheffer RG, Major M, Popovich J Jr, Iannuzzi MC (1998) Angiotensin-converting enzyme gene polymorphism and risk of sarcoidosis. Am J Respir Crit Care Med 158:1566–1570
pubmed: 9817709
Martinetti M, Tinelli C, Kolek V, Cuccia M, Salvaneschi L, Pasturenzi L, Semenzato G, Cipriani A, Bartova A, Luisetti M (1995) “ The sarcoidosis map”: a joint survey of clinical and immunogenetic findings in two European countries. Am J Respir Crit Care Med 152:557–564
pubmed: 7633707
Matsushita E, Asai N, Enomoto A, Kawamoto Y, Kato T, Mii S, Maeda K, Shibata R, Hattori S, Hagikura M (2011) Protective role of Gipie, a Girdin family protein, in endoplasmic reticulum stress responses in endothelial cells. Mol Biol Cell 22:736–747
pubmed: 21289099
pmcid: 3057699
McDougal KE, Fallin MD, Moller DR, Song Z, Cutler DJ, Steiner LL, Cutting GR (2009) Variation in the lymphotoxin-α/tumor necrosis factor locus modifies risk of erythema nodosum in sarcoidosis. J Investig Dermatol 129:1921–1926
pubmed: 19225544
McGrath DS, Foley PJ, Petrek M, Izakovicova-Holla L, Dolek V, Veeraraghavan S, Lympany PA, Pantelidis P, Vasku A, Wells AU (2001) Ace gene I/D polymorphism and sarcoidosis pulmonary disease severity. Am J Respir Crit Care Med 164:197–201
pubmed: 11463587
McIntyre J, McKee K, Loadholt C, Mercurio S, Lin I (1977) Increased HLA-B7 antigen frequency in South Carolina blacks in association with sarcoidosis. In: (eds) Transplantation proceedings, pp 173–176
Medica I, Kastrin A, Maver A, Peterlin B (2007) Role of genetic polymorphisms in ACE and TNF-α gene in sarcoidosis: a meta-analysis. J Hum Genet 52:836–847
pubmed: 17768594
Mempel M, Musette P, Flageul B, Schnopp C, Remling R, Gachelin G, Kourilsky P, Ring J, Abeck D (2002) T-cell receptor repertoire and cytokine pattern in granuloma annulare: defining a particular type of cutaneous granulomatous inflammation. J Investig Dermatol 118:957–966
pubmed: 12060389
Mikuniya T, Nagai S, Takeuchi M, Mio T, Hoshino Y, Miki H, Shigematsu M, Hamada K, Izumi T (2000) Significance of the interleukin-1 receptor antagonist/interleukin-1β ratio as a prognostic factor in patients with pulmonary sarcoidosis. Respiration 67:389–396
pubmed: 10940792
Moller DR, Rybicki BA, Hamzeh NY, Montgomery CG, Chen ES, Drake W, Fontenot AP (2017) Genetic, immunologic, and environmental basis of sarcoidosis. Ann Am Thorac Soc 14:S429–S436
pubmed: 29073364
pmcid: 5822412
Morohashi K, Takada T, Omori K, Suzuki E, Gejyo F (2003) Vascular endothelial growth factor gene polymorphisms in Japanese patients with sarcoidosis. Chest 123:1520–1526
pubmed: 12740269
Mrazek F, Stahelova A, Kriegova E, Fillerova R, Zurkova M, Kolek V, Petrek M (2011) Functional variant ANXA11 R230C: true marker of protection and candidate disease modifier in sarcoidosis. Genes Immun 12:490–494
pubmed: 21562576
Müller-Quernheim J, Pfeifer S, Männel DN, Strausz J, Ferlinz R (1992) Lung-restricted activation of the alveolar macrophage/monocyte system in pulmonary sarcoidosis. Am Rev Respir Dis 145:187–192
pubmed: 1731582
Müller-Quernheim J, Schürmann M, Hofmann S, Gaede KI, Fischer A, Prasse A, Zissel G, Schreiber S (2008) Genetics of sarcoidosis. Clin Chest Med 29:391–414
pubmed: 18539234
Muller SA, Winkelmann R (1966) Necrobiosis lipoidica diabeticorum: histopathologic study of 98 cases. Arch Dermatol 94:1–10
Nakajima T, Tanemura A, Inui S, Katayama I (2009) Venous insufficiency in patients with necrobiosis lipoidica. J Dermatol 36:166–169
pubmed: 19335693
Neefjes J, Jongsma ML, Paul P, Bakke O (2011) Towards a systems understanding of MHC class I and MHC class II antigen presentation. Nat Rev Immunol 11:823–836
pubmed: 22076556
Ngo B, Wigington G, Hayes K, Huerter C, Hillman B, Adler M, Rendell M (2008) Skin blood flow in necrobiosis lipoidica diabeticorum. Int J Dermatol 47:354–358
pubmed: 18377597
Niimi T, Sato S, Tomita H, Yamada Y, Akita K, Maeda H, Kawaguchi H, Sugiura Y, Ueda R (2000) Lack of association with interleukin 1 receptor antagonist and interleukin-1 β gene polymorphisms in sarcoidosis patients. Respir Med 94:1038–1042
pubmed: 11127488
Niimi T, Tomita H, Sato S, Kawaguchi H, Akita K, Maeda H, Sugiura Y, Ueda R (1999) Vitamin D receptor gene polymorphism in patients with sarcoidosis. Am J Respir Crit Care Med 160:1107–1109
Oikarinen A, Mörtenhumer M, Kallioninen M, Savolainen ER (1987) Necrobiosis lipoidica: ultrastructural and biochemical demonstration of a collagen defect. J Investig Dermatol 88:227–232
pubmed: 3805759
Pabst S, Baumgarten G, Stremmel A, Lennarz M, Knüfermann P, Gillissen A, Vetter H, Grohe C (2006) Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol 143:420–426
pubmed: 16487240
pmcid: 1809614
Pabst S, Bradler O, Gillissen A, Nickenig G, Skowasch D, Grohe C (2013) Toll-like receptor-9 polymorphisms in sarcoidosis and chronic obstructive pulmonary disease. In: (eds) Respiratory regulation-the molecular approach. Springer, pp 239–245
Pabst S, Fränken T, Schönau J, Stier S, Nickenig G, Meyer R, Skowasch D, Grohé C (2011) Transforming growth factor-β gene polymorphisms in different phenotypes of sarcoidosis. Eur Respir J 38:169–175
pubmed: 21148227
Pabst S, Karpushova A, Diaz-Lacava A, Herms S, Walier M, Zimmer S, Cichon S, Nickenig G, Nöthen MM, Wienker TF (2010) VEGF gene haplotypes are associated with sarcoidosis. Chest 137:156–163
pubmed: 19741061
Pandey JP, Frederick M, Group AR (2002) TNF-α, IL1-β, and immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis. Hum Immun 63:485–491
Patterson KC, Chen ES (2018) The pathogenesis of pulmonary sarcoidosis and implications for treatment. Chest 153:1432–1442
pubmed: 29224832
Piette EW, Rosenbach M (2016a) Granuloma annulare: clinical and histologic variants, epidemiology, and genetics. J Am Acad Dermatol 75:457–465
pubmed: 27543209
Piette EW, Rosenbach M (2016b) Granuloma annulare: pathogenesis, disease associations and triggers, and therapeutic options. J Am Acad Dermatol 75:467–479
pubmed: 27543210
Piotrowski WJ, Górski P, Pietras T, Fendler W, Szemraj J (2011) The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis. Med Sci Mon Int Med J Exp Clin Res 17:CR598
Pritchard C, Nadarajah K (2004) Tumour necrosis factor α inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients. Ann Rheum Dis 63:318–320
pubmed: 14962969
pmcid: 1754920
Reid SD, Ladizinski B, Lee K, Baibergenova A, Alavi A (2013) Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options. J Am Acad Dermatol 69:783–791
pubmed: 23969033
Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Investig 86:1343–1346
pubmed: 1976655
pmcid: 296868
Roche-Gamón E, Vilata-Corell JJ, Velasco-Pastor M (2007) Familial necrobiosis lipoidica not associated with diabetes. Dermatol Online J 13
Rossman MD, Thompson B, Frederick M, Iannuzzi MC, Rybicki BA, Pander J, Newman LS, Rose C, Magira E, Monos D (2008) HLA and environmental interactions in sarcoidosis. Sarcoidosis Vasculitis Diff Lung Dis Offic J WASOG 25:125–132
Rossman MD, Thompson B, Frederick M, Maliarik M, Iannuzzi MC, Rybicki BA, Pandey JP, Newman LS, Magira E, Beznik-Cizman B (2003) HLA-DRB1* 1101: a significant risk factor for sarcoidosis in blacks and whites. Am J Hum Genet 73:720–735
pubmed: 14508706
pmcid: 1180597
Rubin CB, Rosenbach M (2019) Granuloma annulare: a retrospective series of 133 patients. Cutis 103:102–106
pubmed: 30893387
Rybicki B, Maliarik M, Poisson L, Iannuzzi M (2004) Sarcoidosis and granuloma genes: a family-based study in African-Americans. Eur Respir J 24:251–257
pubmed: 15332393
Rybicki BA, Iannuzzi MC, Frederick MM, Thompson BW, Rossman MD, Bresnitz EA, Terrin ML, Moller DR, Barnard J, Baughman RP (2001) Familial aggregation of sarcoidosis: a case–control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 164:2085–2091
pubmed: 11739139
Rybicki BA, Walewski JL, Maliarik MJ, Kian H, Iannuzzi MC, Group AR (2005) The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites. Am J Hum Genet 77:491–499
Sato H, Grutters JC, Pantelidis P, Mizzon AN, Ahmad T, van Houte A-J, Lammers J-WJ, van den Bosch JM, Welsh KI, du Bois RM (2002) HLA-DQB1* 0201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol 27:406–412
pubmed: 12356573
Sato H, Woodhead FA, Ahmad T, Grutters JC, Spagnolo P, van den Bosch JM, Maier LA, Newman LS, Nagai S, Izumi T (2010) Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet 19:4100–4111
pubmed: 20685690
pmcid: 4351376
Schmitt A, Volz A (2019) Non-infectious granulomatous dermatoses. Journal der Deutschen Dermatologischen Gesellschaft [J Ger Soc Dermatol JDDG] 17:518–533
Schurmann M, Reichel P, Muller-Myhsok B, Schlaak M, Muller-Quernheim J, Schwinger E (2001) Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respirat Crit Care Med 164:840–846
Schürmann M, Reichel P, Müller-Myhsok B, Dieringer T, Wurm K, Schlaak M, Müller-Quernheim J, Schwinger E (2001) Angiotensin-converting enzyme (ACE) gene polymorphisms and familial occurrence of sarcoidosis. J Intern Med 249:77–83
pubmed: 11168787
Seitzer U, Swider C, Stüber F, Suchnicki K, Lange A, Richter E, Zabel P, Müller-Quernheim J, Flad H-D, Gerdes J (1997) Tumour necrosis factor alpha promoter gene polymorphism in sarcoidosis. Cytokine 9:787–790
pubmed: 9344512
Seviour P, Elkeles R (1985) Necrobiosis lipoidica in two diabetic sisters. Clin Exp Dermatol 10:159–161
pubmed: 3978863
Seyhan E, Cetinkaya E, Altin S, Gunluoglu M, Demir A, Koksal V, Issever H (2008) Vascular endothelial growth factor gene polymorphisms in Turkish patients with sarcoidosis. Tissue Antigens 72:162–165
pubmed: 18554246
Sharma P, Smith I (1997) Clinical value of ACE genotyping in diagnosis of sarcoidosis. Lancet 349:1602–1603
pubmed: 9174568
Sharma S, Ghosh B, Sharma S (2008) Association of TNF polymorphisms with sarcoidosis, its prognosis and tumour necrosis factor (TNF)-α levels in Asian Indians. Clin Exp Immunol 151:251–259
pubmed: 18062795
pmcid: 2276943
Shigehara K, Shijubo N, Ohmichi M, Takahashi R, Kon S-i, Okamura H, Kurimoto M, Hiraga Y, Tatsuno T, Abe S (2001) IL-12 and IL-18 are increased and stimulate IFN-γ production in sarcoid lungs. J Immunol 166:642–649
pubmed: 11123348
Shimanovich I, Erdmann H, Grabbe J, Zillikens D, Rose C (2008) Necrobiosis lipoidica in monozygotic twins. Arch Dermatol 144:119–120
pubmed: 18209185
Smith AC, Heo WD, Braun V, Jiang X, Macrae C, Casanova JE, Scidmore MA, Grinstein S, Meyer T, Brumell JH (2007) A network of Rab GTPases controls phagosome maturation and is modulated by Salmonella enterica serovar Typhimurium. J Cell Biol 176:263–268
pubmed: 17261845
pmcid: 2063952
Smith G, Brownell I, Sanchez M, Prystowsky S (2008) Advances in the genetics of sarcoidosis. Clin Genet 73:401–412
pubmed: 18312452
Song GG, Kim J-H, Lee YH (2014) Associations between TNF-α− 308 a/G and lymphotoxin-α+ 252 a/G polymorphisms and susceptibility to sarcoidosis: a meta-analysis. Mol Biol Rep 41:259–267
pubmed: 24197700
Song GG, Kim J-H, Lee YH (2015) Associations between the angiotensin-converting enzyme insertion/deletion polymorphism and susceptibility to sarcoidosis: a meta-analysis. J Renin-Angiotensin-Aldosterone Syst 16:219–226
Song Z, Marzilli L, Greenlee BM, Chen ES, Silver RF, Askin FB, Teirstein AS, Zhang Y, Cotter RJ, Moller DR (2005) Mycobacterial catalase–peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis. J Exp Med 201:755–767
pubmed: 15753209
pmcid: 2212832
Spagnolo P, Renzoni EA, Wells AU, Sato H, Grutters JC, Sestini P, Abdallah A, Gramiccioni E, Ruven HJ, du Bois RM (2003) CC chemokine receptor 2 and sarcoidosis: association with Lofgren’s syndrome. Am J Respir Crit Care Med 168:1162–1166
pubmed: 12882757
Starshinova AA, Malkova AM, Basantsova NY, Zinchenko YS, Kudryavtsev IV, Ershov GA, Soprun LA, Mayevskaya VA, Churilov LP, Yablonskiy PK (2019) Sarcoidosis as an autoimmune disease. Front Immun 10
Sverrild A, Backer V, Kyvik KO, Kaprio J, Milman N, Svendsen CB, Thomsen SF (2008) Heredity in sarcoidosis: a registry-based twin study. Thorax 63:894–896
pubmed: 18535119
Swider C, Schnittger L, Bogunia-Kubik K, Gerdes J, Flod H, Lange A, Seitzer U (1999) TNF- and HLA-DR genotyping as potential prognostic markers in pulmonary sarcoidosis. Eur Cytokine Netw 10:143–146
pubmed: 10400819
Takada T, Suzuki E, Ishida T, Moriyama H, Ooi H, Hasegawa T, Tsukuda H, Gejyo F (2001) Polymorphism in RANTES chemokine promoter affects extent of sarcoidosis in a Japanese population. Tissue Antigens 58:293–298
pubmed: 11844139
ten Berge B, Paats MS, Bergen IM, van den Blink B, Hoogsteden HC, Lambrecht BN, Hendriks RW, KleinJan A (2012) Increased IL-17A expression in granulomas and in circulating memory T cells in sarcoidosis. Rheumatology 51:37–46
pubmed: 22075064
Vadasz Z, Toubi E (2017) FoxP3 expression in macrophages, cancer, and B cells—is it real? Clin Rev Allergy Immunol 52:364–372
pubmed: 27339600
Valentonyte R, Hampe J, Croucher PJ, Müller-Quernheim J, Schwinger E, Schreiber S, Schürmann M (2005a) Study of CC chemokine receptor 2 alleles in sarcoidosis, with emphasis on family-based analysis. Am J Respir Crit Care Med 171:1136–1141
pubmed: 15750046
Valentonyte R, Hampe J, Huse K, Rosenstiel P, Albrecht M, Stenzel A, Nagy M, Gaede KI, Franke A, Haesler R (2005b) Sarcoidosis is associated with a truncating splice site mutation in BTNL2. Nat Genet 37:357–364
pubmed: 15735647
Vázquez-López F, Pereiro M Jr, Haces JM, López MG, Sánchez TS, Coto TF, Oliva NP, Toribio J (2003) Localized granuloma annulare and autoimmune thyroiditis in adult women: a case-control study. J Am Acad Dermatol 48:517–520
pubmed: 12664012
Veerdonk FVD, Netea M (2013) New insights in the immunobiology of IL-1 family members. Front Immunol 4:167
pubmed: 23847614
pmcid: 3703542
Veltkamp M, van Moorsel CH, Rijkers GT, Ruven HJ, Grutters J (2012) Genetic variation in the Toll-like receptor gene cluster (TLR10-TLR1-TLR6) influences disease course in sarcoidosis. Tissue Antigens 79:25–32
pubmed: 22150367
Voorter CE, Drent M, van den Berg-Loonen EM (2005) Severe pulmonary sarcoidosis is strongly associated with the haplotype HLA-DQB1* 0602–DRB1* 150101. Hum Immunol 66:826–835
pubmed: 16112030
Wahlström J, Dengjel J, Persson B, Duyar H, Rammensee H-G, Stevanović S, Eklund A, Weissert R, Grunewald J (2007) Identification of HLA-DR–bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. J Clin Investig 117:3576–3582
pubmed: 17975675
pmcid: 2045606
Wanat K, Rosenbach M (2018) Necrobiosis lipoidica. UpToDate. Waltham (MA): UpToDate. Accessed May 29
Wang J, Khachemoune A (2018) Granuloma annulare: a focused review of therapeutic options. Am J Clin Dermatol 19:333–344
pubmed: 29230666
Wang Z, Liu B, Wang P, Dong X, Fernandez-Hernando C, Li Z, Hla T, Li Z, Claffey K, Smith JD (2008) Phospholipase C β3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice. J Clin Investig 118:195–204
pubmed: 18079968
Yanardag H, Tetikkurt C, Bilir M, Yılmaz E (2017) Association of HLA antigens with the clinical course of sarcoidosis and familial disease. Monaldi Arch Chest Dis 87
Zheng L-Q, Chi S-M, Li C-X (2017) Rab23’s genetic structure, function and related diseases: a review. Bioscience Rep 37
Zheng L, Teschler H, Guzman J, Hübner K, Striz I, Costabel U (1995) Alveolar macrophage TNF-alpha release and BAL cell phenotypes in sarcoidosis. Am J Respir Crit Care Med 152:1061–1066
pubmed: 7663784
Zhou T, Zhang W, Sweiss NJ, Chen ES, Moller DR, Knox KS, Ma S-F, Wade MS, Noth I, Machado RF (2012) Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis. PloS One 7
Zhou Y, Yamaguchi E, Hizawa N, Nishimura M (2005) Roles of functional polymorphisms in the interleukin-18 gene promoter in sarcoidosis. Sarcoidosis Vasculitis Diff Lung Dis Offic J WASOG 22:105–113
Zhu R, Bi L, Kong H, Tilley S, Wang H, Xie W (2015) Meta-analytical association between angiotensin-converting enzyme gene polymorphisms and sarcoidosis risk. Genet Mol Res 14:3590–3600
pubmed: 25966127
Ziegenhagen MW, Rothe ME, Zissel G, Müller-Quernheim J (2002) Exaggerated TNF alpha release of alveolar macrophages in corticosteroid resistant sarcoidosis. Sarcoidosis Vasculitis Diff Lung Dis Offic J WASOG 19:185–190
Zorzetto M, Bombieri C, Ferrarotti I, Medaglia S, Agostini C, Tinelli C, Malerba G, Carrabino N, Beretta A, Casali L (2002) Complement receptor 1 gene polymorphisms in sarcoidosis. Am J Respir Cell Mol Biol 27:17–23
pubmed: 12091241